Submission of applications for Implementation of Knowledge and Innovations in Appropriate Care

21

Jul 2022

The Dutch Organization for Health Research and Development (ZonMw) works to improve disease prevention, healthcare practices, and the health status of the Dutch citizens by stimulating and funding research, development, and implementation of innovative technologies.

The ZonMw Efficiency Research program for 2022-2026 is intended to develop socially relevant and high-quality knowledge about the effectiveness and costs of innovative and existing non-pharmaceutical diagnostic and therapeutic interventions within the basic insurance package or long-term care.

On June 28, 2022, the ZonMw launched a call for subsidy “Implementation of Knowledge and Innovations in Appropriate Care”. The subsidy aims to bring further knowledge to improve care in line with four principles of Appropriate Care (value-driven, joint decision-making, right care in the right place, and positive health). The research may involve knowledge transfer, synthesis, and integration (e.g., in guidelines), practical implementation, dissemination, and upscaling of innovations or interventions, including adaptation to the local context and structural conditions.

The total budget of the program is €5,5 million. Co-financing is not mandatory (10% of the total costs) and must be arranged when submitting the grant application. The maximum amount per research proposal is €250,000.

Subsidy applications shall be submitted until September 13, 2022.

The full details in Dutch can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).

The latest related news

11

Aug 2022

The French National Authority for Health released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies in July 2022. Twenty recommendations were published in relation to the registration, modification of registration conditions, and renewal of registration for devices in the List of reimbursable products and services. Opinions concern cardiovascular and peripheral vascular, neurovascular and neuromodulation, orthopedic, endocrine, and ENT devices, as well as breast implants and medical aids. Except for this, CNEDiMTS published two positive and two negative opinions concerning transitional coverage of devices.

Read more

09

Aug 2022

In May-July 2022, two more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by health insurers.

Read more

05

Aug 2022

In July 2022, Belgian National Institute for Health and Disability Insurance (INAMI-RIZIV) announced the extension of temporary reimbursement for gene expression profile (GEP) testing for early-stage breast cancer detection until December 31, 2022, and for molecular biology tests by next-generation sequencing (NGS) until June 30, 2023.

Read more

27

Jul 2022

The French National Authority for Health released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies in June 2022. Nineteen recommendations were published in relation to the registration, modification of registration conditions, and renewal of registration for devices in the List of reimbursable products and services. Opinions concern cardiovascular, interventional radiology, orthopedic, neurovascular and neuromodulation, ophthalmology, as well as medical aids.

Read more

26

Jul 2022

On June 23, 2022, the National Association of Statutory Health Insurance Physicians (KBV) announced the first steps aimed to expand the utilization of surgical procedures within day case/outpatient settings (reimbursed via the German Uniform Evaluation Standard (EBM) catalog).

Read more